Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer (MBC)
Interventions: DRUG: Gemcitabine|DRUG: Docetaxel|DRUG: Paclitaxel
Sponsor: Eli Lilly and Company